VFDB - anti-virulence compound 5-[2-Cyclohexyl-4-[[1-[5-[(anthracene-2-yl)carbamoyl]pentyl]-1H-1,2,3-triazole-4-yl]methoxy]phenyl]isoxazole-3-carboxylic acid

Acinetobacter

Aeromonas

Anaplasma

Bacillus

Bartonella

Bordetella

Brucella

Burkholderia

Campylobacter

Chlamydia

Clostridium

Corynebacterium

Coxiella

Enterococcus

Escherichia

Francisella

Haemophilus

Helicobacter

Klebsiella

Legionella

Listeria

Mycobacterium

Mycoplasma

Neisseria

Pseudomonas

Rickettsia

Salmonella

Shigella

Staphylococcus

Streptococcus

Vibrio

Yersinia

5-[2-Cyclohexyl-4-[[1-[5-[(anthracene-2-yl)carbamoyl]pentyl]-1H-1,2,3-triazole-4-yl]methoxy]phenyl]isoxazole-3-carboxylic acid

Drug details:
Molecular formula: C₃₉H₃₉N₅O₅

Standard name: 5-[4-[[1-[6-(anthracen-2-ylamino)-6-oxohexyl]triazol-4-yl]methoxy]-2-cyclohexylphenyl]-1,2-oxazole-3-carboxylic acid

Classification: Anthracenes; Benzenoids; Organic compounds;

Curated SMILES: C1CCC(CC1)C2=C(C=CC(=C2)OCC3=CN(N=N3)CCCCCC(=O)NC4=CC5=CC6=CC=CC=C6C=C5C=C4)C7=CC(=NO7)C(=O)O

Chemical structure:

Evidence for compound's anti-virulence activity:

Mycobacterium
Related VFcategory: Exoenzyme
Target: PtpB
Drug effect: Inhibits protein tyrosine phosphatase B (PtpB) to interfere with signal transduction pathways in macrophages.
Max phase: Preclinical (in vitro)
Publication:
Tan LP, et al., 2009. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry. Org Lett 11(22):5102-5.


	Back to Top

2004-2024 NIPB, CAMS&PUMC